StemCells Reviews

Recommend to a friend
Approve of CEO
StemCells President, CEO, and Director Martin M. McGlynn
Martin M. McGlynn
1 Rating
  • Don't work for this company as long as Martin McGlynn is in charge - Extremely poor management at the helm.

    • Work/Life Balance
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Former Employee - Anonymous Employee in Palo Alto, CA
    Former Employee - Anonymous Employee in Palo Alto, CA

    I worked at StemCells

    Doesn't Recommend
    Disapproves of CEO
    Doesn't Recommend
    Disapproves of CEO


    The scientific endeavors are tremendous and quality people for the most part doing the work.


    The CEO and Sr. Management team is completely dysfunctional and makes poor business strategy decisions repeatedly.

    Advice to Management

    Fire the CEO and reorg the board.

StemCells Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters Newark, CA
Size 50 to 149 Employees
Founded Unknown
Type Company - Public (STEM)
Industry Biotech & Pharmaceuticals
Revenue $1 to $5 million (USD) per year

StemCells hopes a small focus will mean big business. The company discovers cell-based therapies to treat diseases of the central nervous system (CNS), such as cerebral palsy and macular degeneration, as well as spinal cord injury. It is researching stem cell and progenitor cell (cells that have developed from stem cells) therapies to repair neural tissue damaged by disease and injury, and has discovered markers for CNS stem cells and a way to reproduce them for transplant. Its lead therapy candidate may treat Batten disease, a fatal genetic enzyme deficiency. In addition ... More

Work at StemCells? Share Your Experiences


Click to Rate